Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_baee372c55802742f9582e25c15ff11a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2016-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2021-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad08b5dc5161058d4fab6eafb94efa4f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9adac9988dd12d8bdf1a90a83a51fc71 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4ba67b544b7007dd9e8674c3bb393bf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_001f6112c0a32cb51ba501a44a022f6e |
publicationDate |
2021-10-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2864712-T3 |
titleOfInvention |
Crystalline FGFR4 Inhibitor Compound and Uses Thereof |
abstract |
A crystalline free base form of the compound: ** (See formula) ** N- (2 - ((6- (3- (2,6-dichloro-3,5-dimethoxyphenyl) -1-methylureido) pyrimidin-4 -yl) amino) -5- (4-ethylpiperazin-1-yl) phenyl) acrylamide |
priorityDate |
2015-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |